PTSD (post-traumatic stress disorder) decisions — 2025

The Board reinstated the 70% rating for PTSD and denied a compensable rating for the right laceration scar associated with right hand Dupuytren's contracture with post-traumatic arthritis of the index finger.

The Board denied the veteran's claims for increased ratings and earlier effective dates, as well as other benefits including total disability based on individual unemployability and special monthly compensation.

The Board granted an initial rating of 70 percent for PTSD, but no higher.

The Board denied the veteran's claims for a higher rating for PTSD, TDIU, service connection for back pain, and an earlier effective date for DEA benefits.

The Board granted a higher initial rating of 70 percent for PTSD and service connection for adjustment disorder with disturbance of conduct, while denying readjudication of the claim for a stomach condition (other than GERD) due to lack of new and relevant evidence.

The Board denied the Veteran's claim for an earlier effective date for service connection for PTSD, finding that May 25, 2016, was the earliest possible effective date.

The Board denied service connection for acid reflux, back pain, bilateral flat feet, left bunion, right bunion and right toe pain, 'black out frequency', right hip pain, bilateral hearing loss, tinnitus, and PTSD as there was no evidence of a current disability or sufficient evidence to support the claim.

The Board granted service connection for epilepsy, unspecified, diabetes mellitus, type II (diabetes), tinnitus, and posttraumatic stress disorder (PTSD). The petition to readjudicate the claims for obstructive sleep apnea and a right shoulder condition based on new evidence was also granted.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support a higher rating or service connection for any of the conditions appealed.

The Board remands the Veteran's claim for an increased rating in excess of 70 percent for an acquired psychiatric disorder, including PTSD and adjustment disorder with mixed anxiety and depressed mood, due to a procedural error by the agency of original jurisdiction.

The Board granted restoration of a 100 percent rating for PTSD, SMC based on housebound status, and eligibility for DEA under 38 U.S.C. Chapter 35 from June 1, 2025.

The Board denied service connection for posttraumatic stress disorder, anxiety disorder, and major depressive disorder as the Veteran does not have a currently diagnosed acquired psychiatric disorder related to his service.

The Board grants service connection for posttraumatic stress disorder (PTSD) related to the Veteran's fear of hostile military or terrorist activity during his service in Southwest Asia.

The Board denied a rating in excess of 70 percent for PTSD but granted an effective date of July 28, 2010, for the award of a 70 percent rating and TDIU.

The Veteran withdrew his appeal in its entirety, including the issues of entitlement to a rating in excess of 50 percent for PTSD and service connection for sleep apnea.

The appeals for a rating in excess of 50 percent for PTSD and service connection for fatty liver have been withdrawn by the Veteran's authorized representative.

The Board denied the veteran's claim for an increased rating in excess of 70 percent for major depressive disorder with anxious distress and post-traumatic stress disorder.

The Veteran's service-connected PTSD with major depressive disorder and anxious distress was granted a 70 percent rating prior to July 14, 2023, and the claim for a higher rating from that date was denied. An earlier effective date of March 4, 2013, for TDIU was also granted.

The Board denied the veteran's claims for service connection for posttraumatic stress disorder (PTSD) and an initial compensable disability rating for allergic rhinitis.

The Board granted service connection for frequent urination, to include as secondary to the Veteran's hypertension, but denied service connection for PTSD and a compensable rating for erectile dysfunction.